MedTrace Logo

The Value of PSP in Predicting Outcome in ICU Surgical Peritonitis Patients

NCT01465711 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2014-12-03

No results posted yet for this study

Summary

The purpose of this study is to determine the diagnostic accuracy of Pancreatic Stone Protein (PSP) in predicting patient outcomes with suspected peritonitis in the Intensive Care Unit after abdominal surgery and compare PPS with other blood parameters, including C-Reactive Protein (CRP), White Cell Count (WCC), Interleucin-6 (IL-6) and Procalcitonin (PCT).

Conditions

  • Peritonitis
  • Sepsis
  • Multiple Organ Failure
  • Death

Interventions

PROCEDURE

All abdominal surgical procedures

Laparotomy, Laparoscopy

PROCEDURE

Intubation

Ventilatory support

RADIATION

Imaging

Abdominal ultrasound Computer Tomography Magnetic Resonance Imaging

Sponsors & Collaborators

  • University of Zurich

    collaborator OTHER

  • University of Magdeburg

    lead OTHER

Principal Investigators

  • Walter Halangk, PhD · University of Magdeburg, Department of General, Visceral and Vascular Surgery, Leipziger Str. 44, DE-39120, Magdeburg, Germany

  • Hans-Ulrich Schulz, MD · University of Magdeburg, Department of General, Visceral and Vascular Surgery, Leipziger Str. 44, DE-39120, Magdeburg, Germany

  • Rolf Graf, PhD · University Hospital Zurich, Department of Surgery, Raemistrasse 100, CH-8091, Zurich, Switzerland

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01465711 on ClinicalTrials.gov